Health Startup Noom Adding GLP-1 Drugs to Med Plan Now
Noom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
This guide reviews which stablecoins are compliant and the standards they must meet. It helps you spot red flags and choose compliant options with confidence.
19,334 articlesNoom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
The latest monthly gauge shows a sharper-than-expected slowdown in manufacturing, fueling investor caution as the pat...
When mining stocks fall, investors want to know the why and what next. This guide breaks down the drivers behind hecl...
Netflix’s ad-supported tier is gaining traction and subscribers are rising, even as the broader market spurs a debate...
As tensions rise, Iran warns of $200 barrels even as the U.S. and IEA launch a massive emergency oil release. The mov...
JPMorgan's Nasdaq Equity Premium Income ETF offers a high monthly yield around 10% but carries equity risk. This arti...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
A new kind of space stock is building recurring AI-powered intelligence from satellites. This article breaks down the...
As AI stocks cool, a rotation toward durable, revenue-generating assets accelerates. A new wheel technology startup i...
As AI adoption accelerates, capital is flowing away from chipmakers toward the data-center backbone—power, cooling, a...
The administration signals a possible tanker escort plan through the Strait of Hormuz, but says the Navy isn’t ready....
A bold claim from Elon Musk has investors buzzing: could SpaceX hit $1 trillion in annual revenue by 2030? This deep ...